Cell and Gene Therapy Bio-Manufacturing Market Exclusive Report on the Latest Revenue and Future Scope

**InsightAce Analytic Pvt. Ltd. Announces Release of Market Assessment Report on Global Cell and Gene Therapy Bio-manufacturing Market**

InsightAce Analytic Pvt. Ltd. proudly announces the release of its comprehensive market assessment report titled:

**“Global Cell and Gene Therapy Bio-manufacturing Market Size, Share & Trends Analysis Report By Product Type (Consumables, Equipment, And Software Solutions), Usage (Commercial-Stage Manufacturing And Research-Stage Manufacturing), Application (Upstream Processing, Harvesting, And Downstream Processing), And End-User (Life Science Companies, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), And Cell Banks) – Market Outlook And Industry Analysis 2034.”**

### Market Overview

The global cell and gene therapy bio-manufacturing market is projected to reach over **USD 40.2 billion by 2034**, exhibiting a robust compound annual growth rate (CAGR) of **11.4%** during the forecast period.

This significant growth is driven by the increasing number of approved therapies and a rising demand for advanced biomanufacturing infrastructure. The expanding range of therapeutic indications for cell and gene therapies has accelerated the need for large-scale manufacturing capabilities.

Over the past decade, approximately **USD 2.3 billion** has been invested in gene therapy companies, highlighting strong interest from major pharmaceutical and biotechnology firms in this fast-evolving sector.

Contract Development and Manufacturing Organizations (CDMOs), Contract Manufacturing Organizations (CMOs), and in-house manufacturers are increasingly viewing cell and gene therapy as a strategic area for capital allocation and business expansion.

### List of Prominent Players in the Cell and Gene Therapy Bio-manufacturing Market

– Becton, Dickinson and Company
– Endress+Hauser Group Services AG (Analytik Jena GmbH)
– Danaher Corporation
– Bio-Rad Laboratories, Inc.
– Bio-Techne Corporation
– General Electric Company (G.E. Healthcare)
– Getinge AB
– Infors AG
– Lonza Group Ltd
– Merck KGaA
– Miltenyi Biotec B.V. & Co. KG
– PIERRE GUERIN
– Sartorius AG (Sartorius Stedim Biotech S.A.)
– Thermo Fisher Scientific Inc.
– WuXi AppTec

### Market Dynamics

#### Drivers
The market is witnessing significant growth, primarily fueled by the increasing prevalence of cancer and other target diseases. According to the International Agency for Research on Cancer (IARC), there were an estimated **19.3 million new cancer cases worldwide in 2020**, underscoring the escalating demand for advanced therapeutic solutions.

#### Challenges
Despite promising growth, the market faces notable challenges, chiefly the high costs associated with advanced therapies. For example, the U.S. Food and Drug Administration (FDA) approved the chimeric antigen receptor T-cell (CAR-T) therapy, *tisagenlecleucel*, for treating certain types of leukemia, with a single infusion priced at approximately **USD 475,000**.

### Regional Trends

**North America** is anticipated to maintain a substantial share of the cell and gene therapy bio-manufacturing market. This is attributed to a well-established healthcare infrastructure and a growing elderly population vulnerable to various diseases.

The United States, in particular, is seeing increased utilization of gene therapies across diagnostic, therapeutic, and drug development applications—especially in oncology. This trend is projected to continue, supported by a rising patient population and the country’s commitment to advancing medical research and innovation.

### Recent Developments

In January 2022, **Allogene Therapeutics Inc.** and **Antion Biosciences Inc.** entered an exclusive collaboration and global license agreement for Antion’s miRNA technology (miCAR). This partnership aims to advance multiplex gene silencing as an additional tool for developing next-generation allogeneic CAR T products.

### Market Segmentation

**By Product Type**
– Consumables
– Culture Supplements, Media, Serum, Macronutrients
– Single-Use Liquids, Cell Culture Reagents, Cell Quantification Kits
– Equipment
– Bioreactors/Fermenters (Continuous & Single-Use)
– Mixing Systems, Cell Counters, Cell Sorters, Centrifuges, Incubators, Biosafety Cabinets, Freezers
– PCR Systems, Transfection Systems, Storage Tanks
– Others
– Software Solutions

**By Usage**
– Commercial Stage Manufacturing
– Research Stage Manufacturing

**By Application**
– Upstream Processing
– Formulation and Hydration
– Cell Culture Processing
– Harvesting
– Downstream Processing
– Separation and Filtration
– Fill and Finish Operations

**By End-User**
– Life Science Companies (Equipment, Consumables, Software Solutions)
– Contract Research Organizations (CROs) (Equipment, Consumables, Software Solutions)
– Contract Manufacturing Organizations (CMOs) (Equipment, Consumables, Software Solutions)
– Cell Banks (Equipment, Consumables, Software Solutions)

**By Region**
– North America: United States, Canada, Mexico
– Europe: Germany, United Kingdom, France, Italy, Spain, Rest of Europe
– Asia-Pacific: China, Japan, India, South Korea, South East Asia, Rest of Asia-Pacific
– Latin America: Brazil, Argentina, Rest of Latin America
– Middle East & Africa: GCC Countries, South Africa, Rest of the Middle East and Africa

### Request for Free Sample Pages

Curious about the latest insights and detailed analysis in this report? **Request your free sample pages today** to explore comprehensive market trends, segment forecasts, and competitive landscape information.

### About InsightAce Analytic Pvt. Ltd.

InsightAce Analytic is a market research and consulting firm dedicated to enabling clients to make strategic business decisions. Our qualitative and quantitative market intelligence solutions offer crucial insights for market and competitive analysis to help businesses expand.

We assist clients in gaining a competitive advantage by identifying untapped markets, exploring new and emerging technologies, segmenting potential markets, and repositioning products. Our expertise lies in delivering syndicated and custom market intelligence reports, providing in-depth analysis and key market insights in a timely and cost-effective manner.

### Contact Us

– Email: [email protected]
– Website: [www.insightaceanalytic.com](http://www.insightaceanalytic.com)
– Phone (USA): +1 607 400-7072
– Phone (Asia): +91 79 72967118

Follow us on Twitter for the latest updates: [@InsightAceAnalytic](https://twitter.com/InsightAceAnalytic)

Unlock the potential of the rapidly growing cell and gene therapy bio-manufacturing market with InsightAce Analytic’s expert research and strategic insights.
https://www.prnewsreleaser.com/news/115868

Leave a Reply

Your email address will not be published. Required fields are marked *